|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1331 Pennsylvania Ave NW |
Address2 | Suite 1425 North |
City | WASHINGTON |
State | DC |
Zip Code | 20004-1710 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60601 |
Country | USA |
|
5. Senate ID# 2811-12
|
||||||||
|
6. House ID# 305490000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul G Billings |
Date | 4/20/2017 5:31:10 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; tobacco control and air pollution; Issues related to the Affordable Care Act; Issues related to the President's Budget; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; Senate Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; House Commerce, Justice, Science, and Related Agencies Appropriations Act, 2017; Senate Department of Defense Appropriations Act, 2017; House Department of Defense Appropriations Act, 2017; Senate Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; House Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; House Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; Senate Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; House Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Issues related to the health impacts of air pollution and climate change; Issues related to air pollution from stationary and mobile sources; Issues related to the Clean Air Act; Issues related to the President's Budget; H.J.Res.22 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of a rule submitted by the Environmental Protection Agency relating to "Oil and Natural Gas Sector: Emission Standards for New, Reconstructed, and Modified Sources"; H.J.Res.36 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation"; H.J.ResS.37 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation"; H.R.5 Regulatory Accountability Act of 2017; H.R.21 Midnight Rules Relief Act of 2017; H.R.26 Regulations from the Executive in Need of Scrutiny Act of 2017; H.R.453 Relief from New Source Performance Standards Act of 2017; H.R.694 Stop EPA Overregulation of Rural Americans Act; H.R.806 Ozone Standards Implementation Act of 2017; H.R.861To terminate the Environmental Protection Agency; H.R.998 SCRUB Act; H.R.1004 Regulatory Integrity Act of 2017; H.R.1009 OIRA Insight, Reform, and Accountability Act; H.R.1355 Crowd Sourcing of Environmental Data Act of 2017; H.R.1430 HONEST Act; H.R.1431 EPA Science Advisory Board Reform Act of 2017; S.21 Regulations from the Executive in Need of Scrutiny Act of 2017; S.34 Midnight Rules Relief Act of 2017; S.56 RED Tape Act of 2017; S.263 Ozone Standards Implementation Act of 2017; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; S.J.Res.11 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation"; S.J.Res.21 Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to Cross-State Air Pollution Rule Update for the 2008 Ozone NAAQS; Senate Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; House Department of the Interior, Environment, and Related Agencies Appropriations Act, 2017; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to tobacco cessation; Issues related to the Affordable Care Act; Issues related to the President's Budget; H.R.774 Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act; H.R.1121 Pre-existing Conditions Protection Act of 2017; H.R.1628 American Health Care Act of 2017; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; House Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Housing & Urban Development - Dept of (HUD), Office of Management & Budget (OMB), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Issues related asthma; COPD; influenza; lung cancer; pneumonia; tuberculosis and other lung diseases; Issues related to lung disease treatment, prevention and research; Issues related to the President's Budget; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; Issues related to tobacco cessation; Issues related to the President's Budget; H.R.774 Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act; H.R.1121 Pre-existing Conditions Protection Act of 2017; H.R.1628 American Health Care Act of 2017; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code POS
16. Specific lobbying issues
Issues related to nonprofit postal rates;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Postal Regulatory Commission
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; public health; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; Senate Department of Defense Appropriations Act, 2017; House Department of Defense Appropriations Act, 2017; Issues related to tobacco cessation; Issues related to the President's Budget; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Billings |
|
|
|
Erika |
Sward |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Issues related to lung disease treatment and prevention, and public health; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the Tobacco Control Act: Issues related to tobacco smuggling; Issues related to the Affordable Care Act; Issues related to the President's Budget; H.R.5 Regulatory Accountability Act of 2017; H.R.21 Midnight Rules Relief Act of 2017; H.R.26 Regulations from the Executive in Need of Scrutiny Act of 2017;H.R.453Relief from New Source Performance Standards Act of 2017; H.R.564 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017; H.R.729 Tobacco Excise Tax and Parity Act of 2017; H.R.774 Medicaid Coverage of Tobacco Cessation Nonprescription Drugs Act; H.R.998 SCRUB Act; H.R.1004Regulatory Integrity Act of 2017; H.R.1009 OIRA Insight, Reform, and Accountability Act; H.R.1136 FDA Deeming Authority Clarification Act of 2017; H.R.1662 To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes; S.21 Regulations from the Executive in Need of Scrutiny Act of 2017; S.34 Midnight Rules Relief Act of 2017; S.56 RED Tape Act of 2017; S.294 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2017; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; Senate Department of Defense Appropriations Act, 2017; House Department of Defense Appropriations Act, 2017; Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; House Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; House Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017; Senate Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; House Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2017; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Housing & Urban Development - Dept of (HUD), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issues related to the President's Budget; H.R.729 Tobacco Excise Tax and Parity Act of 2017; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issues related to lung disease treatment, prevention and research; Issues related to tobacco cessation; Issues related to smokefree air; Issues related to the President's Budget; H.R.1662 To amend title 38, United States Code, to prohibit smoking in any facility of the Veterans Health Administration, and for other purposes; S.Con.Res.3 A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026; Issues related to FY 2018 Appropriations;
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Erika |
Sward |
|
|
|
Paul |
Billings |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |